Beyluxe

Date Time

Sunday, August 10, 2024
EUR
USD
JPY
BGN
CZK
DKK
GBP
HUF
PLN
RON
SEK
CHF
NOK
RUB
TRY
AUD
BRL
CAD
CNY
INR
KRW
MXN
NZD
ZAR
AED
EGP
MDL
RSD
UAH
XAU
XDR
EUR = 1.0000 USD

Business

Novartis is restructuring
April 22, 2025 09:22 GMT

Novartis is restructuring

 

The Swiss drug manufacturer Novartis will conduct a significant restructuring of the product portfolio, which includes many business sale and acquisition of a division of the British company GlaxoSmithKline (GSK) in a series of transactions totaling over $25 billion.

 

Novartis announced on Tuesday that it will take the cancer drugs division of GSK for about $14.5 billion, says the Wall Street Journal.

 

 

Also, the Novartis Vaccines British company is selling operations for $5.25 billion.

 

 

Both transactions include provisions for future payments based on the achievement of future targets, which could increase the final price.